News
2hon MSN
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
Kelly Clarkson's Ex-Husband Brandon Blackstock Dead At 48 What You're Really Eating When You Order Taco Bell Helicopter ...
David Risinger, Leerink Partners senior research analyst, joins 'Power Lunch' to discuss how competitive Eli Lilly's business ...
Fortinet, AppLovin, Airbnb, Duolingo and more stock were making big moves Thursday after the companies reported quarterly ...
Reuters on MSN2h
Dow, S&P 500 end lower; Eli Lilly shares fall after drug data
The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...
CBS News - Video on MSN49m
Eli Lilly reports positive results from new weight loss pill
Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a ...
Investor's Business Daily on MSN12h
Stock Market Today: Dow Futures Rise On Trump Tariff News; Eli Lilly Plunges On Weight-Loss Drug Trial (Live Coverage)
Futures for the Dow Jones Industrial Average and other major stock indexes traded higher in morning action Thursday, as Wall ...
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...
Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body fat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback